Blog: You, us, everyone

Capitalizing on semiconductor innovation, Axcelis Technologies, Inc. designs, manufactures, and services ion implantation in the fabrication of chips around the world. Currency and geopolitical risks have affected the industry in general. While trading at a discount, ACLS has gained amid high demand and outperformed the overall semiconductor industry and S&P 500 over the last year.

Despite trading near its 52-week high of $97.43 per share, ACLS is undervalued. Forward P/E of 18.3x is a -24.98% difference to the sector 24.4x, and its forward PEG of 0.92x is more than -40%. With bullish momentum showcasing substantial quarterly price-performance beats, analysts call the stock overbought as shares are actively being purchased, and the 200-day moving average is upward sloping. In anticipation of Q4 revenues exceeding $250M, above its previous guidance of approximately $232M to $240M, Axcelis raises Q4 guidance, indicating solid growth and profitability anticipated. Expecting to achieve nearly $1B in revenue over the next few years on the heels of growth drivers like the electrification of automobiles and advancements in communications technology. ACLS's targeting of specific markets has helped advance its revenues.